H9N2 (6-2) AA ca Reassortant (A/chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

InfluenzaVirus Diseases

Phase 1

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)

CompletedNCT00110279

National Institute of Allergy and Infectious Diseases (NIAID)Influenza, Virus Diseases

Start: 2005-06-30End: 2005-09-30Updated: 2008-01-21

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)

CompletedNCT00380237

National Institute of Allergy and Infectious Diseases (NIAID)Influenza, Virus Diseases

Start: 2006-10-31End: 2007-01-31Updated: 2008-01-21

Related Papers

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

2009-03-0154 citations